Sep 28, 2022 9:28 am EDT Battling Blindness: Virtual Investor Event on Treatments for Retinitis Pigmentosa to Be Held Oct 19; Panelists include Kiora Pharmaceuticals, Foundation Fighting Blindness, and Retinal Surgeon Christine Kay, M.D.
Sep 15, 2022 12:23 pm EDT Kiora Pharmaceuticals To Participate in the Ladenburg Thalmann 2022 Healthcare Conference
Sep 13, 2022 6:45 am EDT Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance
Aug 12, 2022 6:45 am EDT Kiora Pharmaceuticals Reports First Half 2022 Business Update and Financial Results
Aug 9, 2022 11:00 am EDT Kiora Pharmaceuticals To Participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference; Online Presentation Will Be Available August 17, 2022 at 7:00 am EST
Jul 28, 2022 6:45 am EDT Kiora Pharmaceuticals Issued US Patent Covering KIO-201 Technology in Combination with Antibiotics
Jul 26, 2022 4:38 pm EDT Kiora Pharmaceuticals Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Jul 22, 2022 8:30 am EDT Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering